Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of Type 2 diabetes: 2. Optimization of serine and threonine ether amino acid residues.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples